The risk of venous thromboembolism (VTE) in first degree family members of patients with VTE and the FV:Q(504) mutation.

被引：0
|
作者：
Middeldorp, S
Henkens, CMA
Koopman, MMW
vanPampus, ECM
Hamulyak, K
vanderMeer, J
Prins, MH
Buller, HR
机构：
[1] UNIV AMSTERDAM,ACAD MED CTR,NL-1105 AZ AMSTERDAM,NETHERLANDS
[2] UNIV GRONINGEN HOSP,CTR HAEMOST THROMB ATHEROSCLER & INFLAMMAT RES,GRONINGEN,NETHERLANDS
[3] UNIV HOSP MAASTRICHT,DEPT HAEMATOL,MAASTRICHT,NETHERLANDS
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1124 / 1124
页数：1
相关论文
共 50 条
  • [21] Bleeding Risk in Thrombocytopenic Cancer Patients with Venous Thromboembolism (VTE) Receiving Anticoagulation
    Pemmaraju, Naresh
    Kroll, Michael H.
    Afshar-Kharghan, Vahid
    Oo, Thein H.
    BLOOD, 2012, 120 (21)
  • [22] Venous thromboembolism (VTE) risk in patients with localized urinary tract tumors (UTT)
    Ramos, Jorge
    Wong, Yu-Ning
    Crabb, Simon J.
    Niegisch, Guenter
    Bellmunt, Joaquim
    Ladoire, Sylvain
    Hussain, Syed A.
    Baniel, Jack
    Golshayan, Ali Reza
    Powles, Thomas
    Rosenberg, Jonathan E.
    De Giorgi, Ugo
    Vaishampayan, Ulka N.
    Agarwal, Neeraj
    Pal, Sumanta K.
    Harshman, Lauren Christine
    Necchi, Andrea
    Recine, Federica
    Galsky, Matt D.
    Yu, Evan Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [23] Reassessment of venous thromboembolism and bleeding risk in medical patients receiving VTE prophylaxis
    Tung, Elaine C.
    Yu, Shi-Yuan
    Shah, Kieran
    Kinkade, Angus
    Tejani, Aaron M.
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2020, 26 (01) : 18 - 25
  • [24] Predicting venous thromboembolism (VTE) risk in cancer patients using machine learning
    Townsley, Samir Khan
    Basu, Debraj
    Vora, Jayneel
    Wun, Ted
    Chuah, Chen-Nee
    Shankar, Prabhu R. V.
    HEALTH CARE SCIENCE, 2023, 2 (04): : 205 - 222
  • [25] Venous Thromboembolism (VTE) in Patients With Cholangiocarcinoma: Focus on Risk Factors and Impact on Survival
    Choi, Mun Ki
    Kim, Dong Uk
    Jeon, Hye Kyung
    Lee, Bong Eun
    Kim, Gwang Ha
    Song, Geun Am
    Kang, Dae Hwan
    GASTROENTEROLOGY, 2012, 142 (05) : S452 - S452
  • [26] The incidence of venous thromboembolism and myocardial infarction in family members of patients with the prothrombin 20210G→A mutation.
    Middeldorp, S
    van Thienen, JV
    Meinardi, JR
    Sanson, BJ
    Koopman, MMW
    van der Meer, J
    Büller, HR
    BLOOD, 1998, 92 (10) : 561A - 561A
  • [27] Venous thromboembolism (VTE), pregnancy and risk factors: lack of association with JAK2 mutation
    Myers, B.
    THROMBOSIS RESEARCH, 2009, 123 : S151 - S152
  • [28] Venous Thromboembolism (VTE) Prevention with Semuloparin in Cancer Patients Initiating Chemotherapy: Benefit-Risk Assessment by VTE Risk in SAVE-ONCO
    George, Daniel
    Agnelli, Giancarlo
    Fisher, William
    Kakkar, Ajay
    Lassen, Michael R.
    Mismetti, Patrick
    Mouret, Patrick
    Lawson, Francesca
    Turpie, Alexander G. G.
    BLOOD, 2011, 118 (21) : 96 - 96
  • [29] Defining the Risk: Benefit Ratio of Venous Thromboembolism (VTE) Prophylaxis in Hospitalized Cancer Patients
    Angelini, Dana E.
    Greene, Todd
    Wietzke, Julie N.
    Flanders, Scott A.
    Sood, Suman L.
    BLOOD, 2015, 126 (23)
  • [30] A predictive model to identify patients with venous thromboembolism (VTE) at minimal risk of malignancy.
    Paneesha, Shankaranarayana
    Zhang, W.
    Parsons, N.
    French, K.
    Cheyne, E.
    Bacchu, S.
    Borg, Anton
    Rose, P.
    BLOOD, 2006, 108 (11) : 433A - 433A
12345